<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:pp="http://www.presspage.com/rss/"
     version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom">
                <channel>
                    <title><![CDATA[Newsroom Hospital for Special Surgery]]></title>
                    <link>https://news.hss.edu/</link>
                    <description></description>
                    <language>en-us</language>
                    <lastBuildDate>Tue, 08 Sep 2026 13:00:17 +0200</lastBuildDate>
                    <pubDate>Fri, 18 Oct 2024 04:00:17 +0200</pubDate>
                    <image>
                        <title><![CDATA[Newsroom Hospital for Special Surgery]]></title>
                        <url>https://content.presspage.com/clients/150_2373.png</url>
                        <link>https://news.hss.edu/</link>
                        <width>144</width>
                    </image><item>
                        <title>Triptans, Gepants, Ditans: Which to Recommend First for Migraine?</title>
                        <link>https://news.hss.edu/triptans-gepants-ditans-which-to-recommend-first-for-migraine/</link>
                        <guid>https://news.hss.edu/triptans-gepants-ditans-which-to-recommend-first-for-migraine/</guid><pp:caseid>674743</pp:caseid><description><![CDATA[<p><span>MedCentral featuring </span>Saritha Kosarussavadi, MD, MS</p>]]></description><content:encoded><![CDATA[<p style="margin-left:0px;text-align:start;">According to Med Central, triptans may be more effective in the treatment of migraine compared to many of the recently FDA-approved medications, including the gepants ubrogepant and rimegepant, and the selective serotonin receptor agonist lasmiditan, according to a new<span>&nbsp;</span>study<span>&nbsp;</span>published in the<span>&nbsp;</span><i>BMJ</i>.</p><p style="margin-left:0px;text-align:start;">Although several drug classes of drugs are available for the treatment of<span>&nbsp;</span>migraine, there is still no clear guideline on which should be prescribed first. Physicians generally prescribe NSAIDs first-line and recommend triptans in severe cases or when patients do not respond to NSAIDs.</p><p style="margin-left:0px;text-align:start;">“Triptans are [also] generally more effective than over-the-counter pain relief medication such as acetaminophen,<span>&nbsp;</span>aspirin, or NSAIDs,”<span>&nbsp;</span><a href="https://www.hss.edu/physicians_kosarussavadi-saritha.asp" target="_blank">Saritha Kosarussavadi, MD,<span>&nbsp;</span>MS</a>, neurologist at HSS, told MedCentral. Dr. Kosarussavadi was not involved in the study.</p><p style="margin-left:0px;text-align:start;">Read the full article at <a href="https://www.medcentral.com/neurology/migraine/triptans-gepants-ditans-which-to-recommend-first-for-migraine" target="_blank">medcentral.com</a>.&nbsp;</p>]]></content:encoded><category><![CDATA[news,Neurology,Kosarussavadi]]></category>
            <pubDate>Thu, 17 Oct 2024 21:32:06 -0400</pubDate>
            <enclosure url="https://content.presspage.com/uploads/2373/500_hss-flat-lightblue-logo-01-201130.png?10000" length="0" type="image/png" />
                <pp:image>https://content.presspage.com/uploads/2373/500_hss-flat-lightblue-logo-01-201130.png?10000</pp:image>
                <pp:imageOriginal>https://content.presspage.com/uploads/2373/hss-flat-lightblue-logo-01-201130.png?10000</pp:imageOriginal><pp:imageTitle><![CDATA[HSS_Flat_lightblue_logo-01]]></pp:imageTitle></item></channel>
                    </rss>